Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Centre for Human Genetics, |
RCV001292575 | SCV001519680 | pathogenic | Intellectual developmental disorder, autosomal dominant 64 | 2021-03-19 | criteria provided, single submitter | clinical testing | This variant was classified as Pathogenic following the ACMG guidelines considering that the following criteria were met : PVS1 (Null variant (nonsense in ZNF292, for which loss-of-function is a known mechanism of disease); PS1 (Same amino acid change as a previously established pathogenic variant regardless of nucleotide change. See PMID: 31723249); PM2 (GnomAD and exomes allele count = 1 is less than 5); PP5 (previous submission in ClinVar classifies this variant as Likely Pathogenic). |
Institute of Human Genetics, |
RCV001292575 | SCV005395896 | uncertain significance | Intellectual developmental disorder, autosomal dominant 64 | 2023-10-18 | criteria provided, single submitter | clinical testing | |
University of Washington Center for Mendelian Genomics, |
RCV001261696 | SCV001439005 | likely pathogenic | Neurodevelopmental disorder | no assertion criteria provided | research | ||
OMIM | RCV001292575 | SCV001481147 | pathogenic | Intellectual developmental disorder, autosomal dominant 64 | 2021-02-18 | no assertion criteria provided | literature only |